disufenton sodium has been researched along with Brain Hemorrhage, Cerebral in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronowski, J; Hallevi, H | 1 |
| Cucchiara, BL; Kasner, SE; Lyden, PD; Messe, SR; Sansing, LH | 1 |
| Jauch, EC; Wagner, KR | 1 |
| Buchan, AM; Papadakis, M | 1 |
| Ahlberg, G; Ashwood, TJ; Davalos, A; Davis, SM; Diener, HC; Grotta, JC; Hardemark, HG; Lees, KR; Lyden, PD; Rodichok, L; Shuaib, A; Svensson, HH; Wasiewski, WW | 1 |
| Alderfer, V; Ashwood, T; Davalos, A; Davis, SM; Diener, HC; Grotta, J; Hårdemark, HG; Lees, KR; Lyden, P; Rodichok, L; Shuaib, A; Wasiewski, W | 1 |
| Corbett, D; Del Bigio, MR; Green, AR; Jackson, DM; Peeling, J | 1 |
| Araujo, DM; Lapchak, PA; Purdy, R; Song, D; Wei, J; Zivin, JA | 1 |
1 review(s) available for disufenton sodium and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Translational vehicles for neuroprotection.
Topics: Animals; Benzenesulfonates; Cerebral Hemorrhage; Disease Models, Animal; Humans; Neuroprotective Agents; Protein Biosynthesis; Stroke; Thrombolytic Therapy | 2006 |
3 trial(s) available for disufenton sodium and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Anti-adrenergic medications and edema development after intracerebral hemorrhage.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Antioxidants; Benzenesulfonates; Blood Pressure; Brain Edema; Cerebral Hemorrhage; Clonidine; Cohort Studies; Critical Care; Double-Blind Method; Drug Therapy, Combination; Female; Free Radical Scavengers; Glasgow Coma Scale; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Treatment Outcome | 2011 |
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antioxidants; Benzenesulfonates; Brain; Cerebral Arteries; Cerebral Hemorrhage; Disability Evaluation; Double-Blind Method; Down-Regulation; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Placebos; Potassium; Time Factors; Treatment Outcome | 2007 |
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
Topics: Age Factors; Aged; Antioxidants; Benzenesulfonates; Brain; Brain Ischemia; Cerebral Hemorrhage; Cerebral Infarction; Comorbidity; Double-Blind Method; Drug Administration Schedule; Emergency Medical Services; Encephalitis; Female; Humans; Hyperglycemia; Injections, Intravenous; Male; Meta-Analysis as Topic; Middle Aged; Neuroprotective Agents; Placebos; Prognosis; Stroke; Treatment Failure | 2008 |
4 other study(ies) available for disufenton sodium and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Life after SAINT.
Topics: Albumins; Antioxidants; Benzenesulfonates; Caffeine; Cerebral Hemorrhage; Clinical Trials, Phase II as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Ethanol; Fibrinolytic Agents; Glyburide; Humans; Magnesium; Neurons; Neuroprotective Agents; Recombinant Proteins; Reperfusion; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Failure | 2007 |
Extending the window for acute stroke treatment: thrombolytics plus CNS protective therapies.
Topics: Acute Disease; Animals; Benzenesulfonates; Central Nervous System; Cerebral Hemorrhage; Disease Models, Animal; Drug Therapy, Combination; Fibrinolytic Agents; Free Radical Scavengers; Humans; Hypothermia, Induced; Neuroprotective Agents; Nitrogen Oxides; Oxidative Stress; Stroke; Tenecteplase; Time Factors; Tissue Plasminogen Activator | 2004 |
Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke.
Topics: Animals; Behavior, Animal; Benzenesulfonates; Blood Cell Count; Body Weight; Brain; Cell Death; Cerebral Hemorrhage; Disease Models, Animal; Free Radical Scavengers; Hematoma; Infusion Pumps; Injections, Subcutaneous; Magnetic Resonance Imaging; Male; Motor Skills; Neuroprotective Agents; Neutrophil Infiltration; Nitrogen Oxides; Pilot Projects; Rats; Rats, Sprague-Dawley; Stroke; Treatment Outcome | 2001 |
Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
Topics: Animals; Benzenesulfonates; Blood Glucose; Body Temperature; Cerebral Hemorrhage; Disease Models, Animal; Drug Therapy, Combination; Fibrinolytic Agents; Intracranial Embolism; Male; Neuroprotective Agents; Nitrogen Oxides; Rabbits; Stroke; Tissue Plasminogen Activator; Treatment Outcome | 2002 |